Luteolin Attenuates Cardiac IschemiaReperfusion Injury in Diabetic Rats by Modulating Nrf2 Antioxidative Function
المؤلفون المشاركون
Xiao, Chi
Xia, Man-Li
Wang, Jue
Zhou, Xin-Ru
Lou, Yang-Yun
Tang, Li-Hui
Zhang, Feng-Jiang
Yang, Jin-Ting
Qian, Ling-Bo
المصدر
Oxidative Medicine and Cellular Longevity
العدد
المجلد 2019، العدد 2019 (31 ديسمبر/كانون الأول 2019)، ص ص. 1-9، 9ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2019-04-08
دولة النشر
مصر
عدد الصفحات
9
التخصصات الرئيسية
الملخص EN
Luteolin has been reported to attenuate ischemia/reperfusion (I/R) injury in the diabetic heart through endothelial nitric oxide synthase- (eNOS-) related antioxidative response.
Though the nuclear factor erythroid 2-related factor 2 (Nrf2) is regarded as a key endogenous factor to reduce diabetic oxidative stress, whether luteolin reduces cardiac I/R injury in the diabetic heart via enhancing Nrf2 function needs to be clarified.
We hypothesized that pretreatment with luteolin could alleviate cardiac I/R injury in the diabetic heart by affecting the eNOS/Nrf2 signaling pathway.
The diabetic rat was produced by a single injection of streptozotocin (65 mg/kg, i.p.) for 6 weeks, and then, luteolin (100 mg/kg/day, i.g.), eNOS inhibitor L-NAME, or Nrf2 inhibitor brusatol was administered for the succedent 2 weeks.
After that, the isolated rat heart was exposed to 30 min of global ischemia and 120 min of reperfusion to establish I/R injury.
Luteolin markedly ameliorated cardiac function and myocardial viability; upregulated expressions of heme oxygenase-1, superoxide dismutase, glutathione peroxidase, and catalase; and reduced myocardial lactate dehydrogenase release, malondialdehyde, and 8-hydroxydeoxyguanosine in the diabetic I/R heart.
All these ameliorating effects of luteolin were significantly reversed by L-NAME or brusatol.
Luteolin also markedly reduced S-nitrosylation of Kelch-like ECH-associated protein 1 (Keap1) and upregulated Nrf2 and its transcriptional activity.
This effect of luteolin on Keap1/Nrf2 signaling was attenuated by L-NAME.
These data reveal that luteolin protects the diabetic heart against I/R injury by enhancing eNOS-mediated S-nitrosylation of Keap1, with subsequent upregulation of Nrf2 and the Nrf2-related antioxidative signaling pathway.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Zhou, Xin-Ru& Lou, Yang-Yun& Tang, Li-Hui& Zhang, Feng-Jiang& Yang, Jin-Ting& Qian, Ling-Bo…[et al.]. 2019. Luteolin Attenuates Cardiac IschemiaReperfusion Injury in Diabetic Rats by Modulating Nrf2 Antioxidative Function. Oxidative Medicine and Cellular Longevity،Vol. 2019, no. 2019, pp.1-9.
https://search.emarefa.net/detail/BIM-1202861
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Zhou, Xin-Ru…[et al.]. Luteolin Attenuates Cardiac IschemiaReperfusion Injury in Diabetic Rats by Modulating Nrf2 Antioxidative Function. Oxidative Medicine and Cellular Longevity No. 2019 (2019), pp.1-9.
https://search.emarefa.net/detail/BIM-1202861
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Zhou, Xin-Ru& Lou, Yang-Yun& Tang, Li-Hui& Zhang, Feng-Jiang& Yang, Jin-Ting& Qian, Ling-Bo…[et al.]. Luteolin Attenuates Cardiac IschemiaReperfusion Injury in Diabetic Rats by Modulating Nrf2 Antioxidative Function. Oxidative Medicine and Cellular Longevity. 2019. Vol. 2019, no. 2019, pp.1-9.
https://search.emarefa.net/detail/BIM-1202861
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1202861
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر